Literature DB >> 15211106

Implication of Reg I in human pancreatic duct-like cells in vivo in the pathological pancreas and in vitro during exocrine dedifferentiation.

Didier Sanchez1, Valery Gmyr, Julie Kerr-Conte, Gunter Kloppel, Michael E Zenilman, Odette Guy-Crotte, François Pattou, Catherine Figarella.   

Abstract

A feature associated frequently with the pathologic pancreas is the presence of tubular complexes produced by a phenotypic modulation of acinar cells that take on the characteristics of ductular cells. Since the type I Reg gene, an acinar cell product, is increased in the pancreas following an acinar injury, we aimed to evaluate whether the Reg I protein might be involved in this dedifferentiation process in the human pancreas. We studied duct-like structures in fixed human pathologic pancreatic tissues and human cells with a ductal phenotype obtained by culturing human exocrine preparations. Immunocytochemistry, Western blotting, and RT-PCR were applied for detection of type I Reg. Reg I was observed not only in acinar cells but also in the duct-like cells and dilated duct cells, both positive for cytokeratin 19. However, none of the other acinar markers was observed in these cells. In vitro, human acinar cells dedifferentiated, losing their acinar phenotype, but expression of Reg I remained constant throughout the culture duration. Furthermore, Reg I was not associated with proliferation. We demonstrated that Reg I expression was linked to acinar cell dedifferentiation. We postulate that Reg I might be used as a marker to understand the events leading to phenotypic changes of acinar cells to address the physiological role of Reg I in the pancreas.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15211106     DOI: 10.1097/00006676-200407000-00050

Source DB:  PubMed          Journal:  Pancreas        ISSN: 0885-3177            Impact factor:   3.327


  5 in total

1.  Persistent hyperinsulinemic hypoglycemia of infancy: constitutive activation of the mTOR pathway with associated exocrine-islet transdifferentiation and therapeutic implications.

Authors:  Sanda Alexandrescu; Nina Tatevian; Oluyinka Olutoye; Robert E Brown
Journal:  Int J Clin Exp Pathol       Date:  2010-08-08

2.  Regenerating islet-derived 1α (Reg-1α) protein is new neuronal secreted factor that stimulates neurite outgrowth via exostosin Tumor-like 3 (EXTL3) receptor.

Authors:  Isabelle Acquatella-Tran Van Ba; Stéphane Marchal; Florence François; Michèle Silhol; Coline Lleres; Bernard Michel; Yves Benyamin; Jean-Michel Verdier; Françoise Trousse; Anne Marcilhac
Journal:  J Biol Chem       Date:  2011-12-09       Impact factor: 5.157

3.  Pancreatic regenerating protein I in chronic pancreatitis and aging: implications for new therapeutic approaches to diabetes.

Authors:  Martin Bluth; Cathy M Mueller; Joelle Pierre; Gordon Callender; Emad Kandil; Domenico Viterbo; Sophia L Fu; Akira Sugawara; Hiroshi Okamoto; Michael E Zenilman
Journal:  Pancreas       Date:  2008-11       Impact factor: 3.327

4.  Prospective markers for early diagnosis and prognosis of sporadic pancreatic ductal adenocarcinoma.

Authors:  Martin Tobi; Mijin Kim; Douglas H Weinstein; Mary Ann Rambus; James Hatfield; N Volkan Adsay; Edi Levi; Douglas Evans; Michael J Lawson; Suzanne Fligiel
Journal:  Dig Dis Sci       Date:  2012-09-22       Impact factor: 3.199

5.  Pancreatic regenerating gene I and acinar cell differentiation: influence on cellular lineage.

Authors:  Didier Sanchez; Cathy M Mueller; Michael E Zenilman
Journal:  Pancreas       Date:  2009-07       Impact factor: 3.327

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.